Active Ingredient: Ondansetron
For this indication, competent medicine agencies globally authorize below treatments:
Oral
16 - 16 mg
From 16 To 16 mg once every day
Ondansetron can be administered orally.
For oral administration: 16mg one hour prior to anaesthesia.
Intravenous
4 - 4 mg
From 4 To 4 mg once every day
Ondansetron can be administered by intravenous injection.
Ondansetron may be administered as a single dose of 4 mg given by slow intravenous injection at induction of anaesthesia.
For treatment of established PONV: A single dose of 4 mg given by slow intravenous injection is recommended.
Intramuscular
4 - 4 mg
From 4 To 4 mg once every day
Ondansetron can be administered orally or by intramuscular injection.
Ondansetron may be administered as a single dose of 4 mg given by intramuscular injection at induction of anaesthesia.
For treatment of established PONV: A single dose of 4 mg given by intramuscular injection is recommended.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
